Publicacións (180) Publicacións de Eva Poveda López

2023

  1. High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients

    Microorganisms, Vol. 11, Núm. 10

  2. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  3. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  4. Meningococcal carriage in men who have sex with men presenting at a sexual health unit in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 3, pp. 287-296

  5. Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

    Clinical Infectious Diseases

2022

  1. Author Correction: Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study (Scientific Reports, (2022), 12, 1, (3369), 10.1038/s41598-022-07414-x)

    Scientific Reports

  2. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

    PLoS ONE, Vol. 17, Núm. 7 July

  3. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  4. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

    Scientific reports, Vol. 12, Núm. 1, pp. 3369

  5. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

    The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049

  6. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  7. Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)

    Antiviral Therapy, Vol. 27, Núm. 4

  8. Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain

    Frontiers in Public Health, Vol. 10

  9. SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

    Microorganisms, Vol. 10, Núm. 1

  10. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

    Microorganisms, Vol. 10, Núm. 2

  11. Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection

    Microorganisms, Vol. 10, Núm. 5

2021

  1. Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen

    ACS Omega, Vol. 6, Núm. 51, pp. 35657-35666

  2. Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysis

    Global Health Action, Vol. 14, Núm. 1

  3. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  4. Characterizing hiv-1 genetic subtypes and drug resistance mutations among children, adolescents and pregnant women in sierra leone

    Genes, Vol. 12, Núm. 9